Status:
COMPLETED
Restrictive vs Goal Directed Fluid Therapy During Hepatobiliary Surgery
Lead Sponsor:
Erasme University Hospital
Collaborating Sponsors:
Bicetre Hospital
Conditions:
Liver Surgery
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
"Restrictive" fluid management is usually the current standard practice for patients undergoing liver surgery. The general idea is to maintain a low central venous pressure in order to decrease blood ...
Detailed Description
Restrictive fluid administration aiming at maintaining a low central venous pressure (low-CVP) during liver surgery has always been considered as a "gold standard" strategy because it decrease blood l...
Eligibility Criteria
Inclusion
- All adults patients undergoing a liver surgery and equipped with a cardiac output monitoring device
Exclusion
- Atrial fibrillation
Key Trial Info
Start Date :
September 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04092608
Start Date
September 4 2019
End Date
July 30 2020
Last Update
August 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasme Hospital
Brussels, Brussel-hoofdstad, Belgium, 1070